Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
Robert V. Rawson, Chandra Mani Adhikari, Carolien Bierman, Serigne Lo, Elena Shklovskaya, Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi, Kerwin F. Shannon, Maria Gonzalez, Alexander Guminski, M.T. Tetzlaff, Jonathan R. Stretch, Hanna Eriksson, Johannes V. van Thienen, Michel W.J.M. Wouters, John B.A.G. Haanen, W. Martin C. Klop, Charlotte L. Zuur, Winan J. van Houdt, Omgo E. Nieweg, Sydney Ch’ng, Helen Rizos, Robyn P.M. Saw, Andrew J. Spillane, James S. Wilmott, Christian U. Blank, Georgina V. Long, Bart A. van de Wiel, Richard A. Scolyer
Topics & Concepts
MedicineMelanomaNeoadjuvant therapyImmunotherapyIpilimumabLymph nodePathologicalOncologyNivolumabBiomarkerStage (stratigraphy)PathologyInternal medicineCancerBreast cancerCancer researchBiochemistryPaleontologyBiologyChemistryCutaneous Melanoma Detection and ManagementCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses